ExxonMobil and Synthetic Genomics, Inc. to Brief Media on Algae Research Breakthrough at 2017 BIO International Convention

SAN DIEGO--(BUSINESS WIRE)-- Scientists from Exxon Mobil Corporation (NYSE:XOM) and Synthetic Genomics, Inc. will hold a press briefing today at the 2017 BIO International Convention in San Diego to discuss a breakthrough in the companies’ research into the development of algae biofuels involving the modification of an algae strain that more than doubled its oil production without significantly inhibiting the strain’s growth. Results of the research were published today in the peer-reviewed journal Nature Biotechnology. A press release is available at www.exxonmobil.com and www.syntheticgenomics.com.

Vijay Swarup, vice president for research and development at ExxonMobil Research & Engineering Company, J. Craig Venter, Ph.D., co-founder and chairman of Synthetic Genomics, and Oliver Fetzer, Ph.D., chief executive officer at Synthetic Genomics, will discuss the research breakthrough and answer questions from media.

The press briefing is scheduled for 10 a.m. PDT at the San Diego Convention Center, located at 111 W. Harbor Drive, in Room 32B on the upper level. The live briefing and replay may also be accessed online via an interactive webcast.

Cautionary Statement: Statements of future events or conditions in this release are forward-looking statements. Actual future results, including the timing, results and impact of new technologies, could differ significantly depending on the outcome of further research and testing; the development and competitiveness of alternative technologies; the ability to develop and scale pilot projects on a cost-effective basis; political and regulatory developments; and other factors discussed in this release and under the heading “Factors Affecting Future Results” on the Investors page of ExxonMobil’s website at exxonmobil.com.

About ExxonMobil

ExxonMobil, the largest publicly traded international energy company, uses technology and innovation to help meet the world’s growing energy needs. ExxonMobil holds an industry-leading inventory of resources, is one of the largest refiners and marketers of petroleum products and its chemical company is one of the largest in the world. For more information, visit www.exxonmobil.com or follow us on Twitter www.twitter.com/exxonmobil.

About Synthetic Genomics

Synthetic Genomics is programming the operating system of life to create sustainable solutions for humankind’s most pressing issues, from the wellbeing of our population to the health of our planet. With an unmatched understanding of how DNA drives the function of cells — the basic biological units of all living organisms — Synthetic Genomics modifies and writes genomes to enable transformative products in the areas of vaccines, medicines, nutrition, and biotechnology research. In addition to designing novel organisms that overcome fundamental hurdles of scientific research and medicine, Synthetic Genomics pursues partnerships with organizations seeking to dramatically improve upon existing products in health care, energy, and other sectors. Continuing its legacy of scientific firsts in genomics and synthetic biology, Synthetic Genomics is harnessing the power of nature to improve quality of life. More information is available at www.syntheticgenomics.com.

Media Relations, 972-444-1107
Synthetic Genomics
Media Relations, 619-849-6005

Source: Exxon Mobil Corporation